A systematic framework for the design, simulation and optimization of personalized healthcare: Making and healing blood

[1]  H. Preisler,et al.  Distribution of cell cycle times amongst the leukemia cells within individual patients with acute myelogenous leukemia. , 1995, Leukemia research.

[2]  Leon Hirsch.  Bioreactors For Tissue Engineering Principles Design And Operation , 2016 .

[3]  C. Maranas,et al.  Recent advances in the reconstruction of metabolic models and integration of omics data. , 2014, Current opinion in biotechnology.

[4]  K. Kaushansky,et al.  Comprar Williams Hematology 8th Ed + DVD | Ernest Beutler | 9780071621519 | Mcgraw-Hill Education , 2010 .

[5]  David O. Morgan,et al.  The Cell Cycle: Principles of Control , 2014 .

[6]  Howard C. Zisser,et al.  Clinical Evaluation of a Personalized Artificial Pancreas , 2013, Diabetes Care.

[7]  U. Günther,et al.  Hypoxia Triggers Major Metabolic Changes in AML Cells without Altering Indomethacin-Induced TCA Cycle Deregulation , 2010, ACS chemical biology.

[8]  Athanasios Mantalaris,et al.  Long-term cytokine-free expansion of cord blood mononuclear cells in three-dimensional scaffolds. , 2011, Biomaterials.

[9]  Andreas A Linninger,et al.  Interspecies scaling in pharmacokinetics: a novel whole-body physiologically based modeling framework to discover drug biodistribution mechanisms in vivo. , 2012, Journal of pharmaceutical sciences.

[10]  Efstratios N. Pistikopoulos,et al.  A mathematical model of subpopulation kinetics for the deconvolution of leukaemia heterogeneity , 2015, Journal of The Royal Society Interface.

[11]  Efstratios N. Pistikopoulos,et al.  'Closing the loop' in biological systems modeling - From the in silico to the in vitro , 2011, Autom..

[12]  L. Geris,et al.  The importance of vascularization for successful bone tissue engineering , 2014 .

[13]  R. Henschler,et al.  Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy , 2001, Bone Marrow Transplantation.

[14]  Catherine Marcucci,et al.  The American Rare Donor Program. , 2013, Journal of critical care.

[15]  Henri Wajcman,et al.  Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo , 2002, Nature Biotechnology.

[16]  Efstratios N. Pistikopoulos,et al.  Modeling and Analysis of Individualized Pharmacokinetics and Pharmacodynamics for Volatile Anesthesia , 2014, IEEE Transactions on Biomedical Engineering.

[17]  Harvey M. Wagner,et al.  Global Sensitivity Analysis , 1995, Oper. Res..

[18]  I. Sobola,et al.  Global sensitivity indices for nonlinear mathematical models and their Monte Carlo estimates , 2001 .

[19]  Efstratios N. Pistikopoulos,et al.  Robust Superstructure Optimisation of a Bioreactor that Produces Red Blood Cells , 2014 .

[20]  Athanasios Mantalaris,et al.  Engineering a mimicry of bone marrow tissue ex vivo. , 2005, Journal of bioscience and bioengineering.

[21]  M. Berridge,et al.  The level of glycolytic metabolism in acute myeloid leukemia blasts at diagnosis is prognostic for clinical outcome , 2011, Journal of leukocyte biology.

[22]  E. Pistikopoulos,et al.  Key environmental stress biomarker candidates for the optimisation of chemotherapy treatment of leukaemia , 2014 .

[23]  Efstratios N. Pistikopoulos,et al.  Chemotherapy Drug Scheduling for the Induction Treatment of Patients With Acute Myeloid Leukemia , 2014, IEEE Transactions on Biomedical Engineering.

[24]  Jeremy C. Pamplin,et al.  A bedside communication tool did not improve the alignment of a multidisciplinary team's goals for intensive care unit patients. , 2013, Journal of critical care.

[25]  Raj Jena,et al.  Optimal dosing of cancer chemotherapy using model predictive control and moving horizon state/parameter estimation , 2012, Comput. Methods Programs Biomed..

[26]  Lars K Nielsen,et al.  Blood cell manufacture: current methods and future challenges. , 2009, Trends in biotechnology.

[27]  Arkadi Nemirovski,et al.  Robust solutions of Linear Programming problems contaminated with uncertain data , 2000, Math. Program..

[28]  E. Pistikopoulos,et al.  Towards unravelling the kinetics of an acute myeloid leukaemia model system under oxidative and starvation stress: a comparison between two- and three-dimensional cultures , 2015, Bioprocess and Biosystems Engineering.

[29]  L. Douay,et al.  Large‐scale production of red blood cells from stem cells: What are the technical challenges ahead? , 2014, Biotechnology journal.

[30]  Gürkan Sin,et al.  A computer-aided framework for development, identification and management of physiologically-based pharmacokinetic models , 2014, Comput. Chem. Eng..

[31]  Athanasios Mantalaris,et al.  Biology Of Mixed Phenotype Acute Leukemia In Successful Long-Term Cytokine-Free Three-Dimensional (3D) Static and Perfused 3D Hollow-Fibre Bioreactor Culture , 2013 .

[32]  Efstratios N. Pistikopoulos,et al.  Design of optimal patient-specific chemotherapy protocols for the treatment of acute myeloid leukemia (AML) , 2013, Comput. Chem. Eng..

[33]  L. Braddy,et al.  Antigen‐matched donor blood in the transfusion management of patients with sickle cell disease , 1994, Transfusion.

[34]  Yongchang Wei,et al.  Involvement of Oxidative Stress in the Relapse of Acute Myeloid Leukemia* , 2010, The Journal of Biological Chemistry.

[35]  Hugo Macedo.  A novel 3D dual hollow fibre bioreactor for the production of human red blood cells , 2011 .

[36]  Efstratios N. Pistikopoulos,et al.  Global superstructure optimisation of red blood cell production in a parallelised hollow fibre bioreactor , 2014, Comput. Chem. Eng..

[37]  Athanasios Mantalaris,et al.  The development of a three-dimensional scaffold for ex vivo biomimicry of human acute myeloid leukaemia. , 2010, Biomaterials.

[38]  Sergei S. Kucherenko,et al.  On global sensitivity analysis of quasi-Monte Carlo algorithms , 2005, Monte Carlo Methods Appl..

[39]  Robert S. Parker,et al.  Clinically relevant cancer chemotherapy dose scheduling via mixed-integer optimization , 2009, Comput. Chem. Eng..

[40]  Efstratios N. Pistikopoulos,et al.  Modelling of the Insulin Delivery System for patients with Type 1 Diabetes Mellitus , 2011 .

[41]  Efstratios N. Pistikopoulos,et al.  A framework for the design, modeling and optimization of biomedical systems , 2014 .

[42]  Maria Margarida Diogo,et al.  Stem cell cultivation in bioreactors. , 2011, Biotechnology advances.

[43]  Athanasios Mantalaris,et al.  Simulation of ex vivo bone marrow culture: Application to chronic myeloid leukaemia growth model , 2012 .

[44]  Efstratios N. Pistikopoulos,et al.  Global Sensitivity Analysis Challenges in Biological Systems Modeling , 2009 .

[45]  Christodoulos A. Floudas,et al.  A Framework for Globally Optimizing Mixed-Integer Signomial Programs , 2013, Journal of Optimization Theory and Applications.

[46]  Efstratios N. Pistikopoulos,et al.  Developing a cyclin blueprint as a tool for mapping the cell cycle in GS-NS0 , 2013 .

[47]  Gilles Clermont,et al.  A model of neutrophil dynamics in response to inflammatory and cancer chemotherapy challenges , 2013, Comput. Chem. Eng..

[48]  Ioannis P. Androulakis,et al.  A chemical engineer's perspective on health and disease , 2014, Comput. Chem. Eng..

[49]  Efstratios N. Pistikopoulos,et al.  A Cyclin Distributed Cell Cycle Model in GS-NS0 , 2014 .

[50]  Graeme Wake,et al.  A mathematical model for analysis of the cell cycle in cell lines derived from human tumors , 2003, Journal of mathematical biology.

[51]  Christodoulos A. Floudas,et al.  GloMIQO: Global mixed-integer quadratic optimizer , 2012, Journal of Global Optimization.

[52]  Michael C Mackey,et al.  A mathematical model of hematopoiesis--I. Periodic chronic myelogenous leukemia. , 2005, Journal of theoretical biology.